Transce3nd’s US Physical Therapy USPH Stock Holding History

Transce3nd’s Portfolio USPH Stock Details USPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-1	Closed	-$89	–	1577
2024 Q4	$89	Buy	+1	New	+$89	﹤0.01%	1520

Other funds holding USPH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SAM

Southernsun Asset Management Memphis, Tennessee $690M AUM 30.68% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Transce3nd's USPH Position: Q1 2025 in Review

Transce3nd sold out of US Physical Therapy (USPH) in Q1 2025, closing a stake of 1 share — an estimated $89 sold.

Transce3nd first reported a position in USPH in Q4 2024 and held it in 1 quarter. The position peaked at $89 in Q4 2024. 253 funds tracked by Wall St. Rank hold USPH as of Q1 2025.

Transce3nd reported no remaining US Physical Therapy position as of Q1 2025 after selling out during the quarter.
Transce3nd sold 1 US Physical Therapy share in Q1 2025, an estimated $89.
Transce3nd first reported a position in US Physical Therapy in Q4 2024 and held it in 1 quarter.
Transce3nd's US Physical Therapy position peaked at $89 in Q4 2024.
253 funds tracked by Wall St. Rank held US Physical Therapy as of Q1 2025.

Based on Transce3nd's 13F filing for Q1 2025, filed 5 May 2025.